SEARCH

SEARCH BY CITATION

References

  • Amory JK, Bremner WJ. Regulation of testicular function in men: implications for male hormonal contraceptive development. J Steroid Biochem Mol Biol. 2003;85: 357361.
  • Anawalt BD, Bebb RA, Bremner WJ, Matsumoto AM. A lower dosage levonorgestrel and testosterone combination effectively suppresses spermatogenesis and circulating gonadotropin levels with fewer metabolic effects than higher dosage combinations. J Androl. 1999;20: 407414.
  • Anderson RA, Baird DT. Male contraception. Endocr Rev. 2002;23: 735762.
  • Aribarg A., Kenkeerati W., Vorapaiboonsak V., Leepipatpaiboon S., Farley TM. Testicular volume, semen profile and serum hormone levels in fertile Thai males. Int J Androl. 1986;9: 170180.
  • Behre HM, Abshagen K., Oettel M., Hubler D., Nieschlag E.. Intramuscular injection of testosterone undecanoate for the treatment of male hypogonadism: phase I studies. Eur J Endocrinol. 1999;140: 414419.
  • Behre HM, Nashan D., Nieschlag E.. Objective measurement of testicular volume by ultrasonography: evaluation of the technique and comparison with orchidometer estimates. Int J Androl. 1989;12: 395403.
  • Fotherby K., Hamawi A., Howard G., Bye PG, Elder M.. Pharmacokinetics of different doses of norethisterone oenanthate. Contraception. 1984;29: 325333.
  • Gapstur SM, Gann PH, Kopp P., Colangelo L., Longcope C., Liu K.. Serum androgen concentrations in young men: a longitudinal analysis of associations with age, obesity, and race. The CARDIA male hormone study. Cancer Epidemiol Biomark Prev. 2002;11: 10411047.
  • Glass AR, Swerdloff RS, Bray GA, Dahms WT, Atkinson RL. Low serum testosterone and sex-hormone-binding-globulin in massively obese men. J Clin Endocrinol Metab. 1977;45: 12111219.
  • Gu YQ, Wang XH, Xu D., Peng L., Cheng LF, Huang MK, Huang ZJ, Zhang GY. A multicenter contraceptive efficacy study of injectable testosterone undecanoate in healthy Chinese men. J Clin Endocrinol Metab. 2003;88: 562568.
  • Handelsman DJ, Conway AJ, Boylan LM, Turtle JR. Testicular function in potential sperm donors: normal ranges and the effects of smoking and varicocele. Int J Androl. 1984;7: 369382.
  • Jensen TK, Andersson AM, Jorgensen N., Andersen AG, Carlsen E., Petersen JH, Skakkebaek NE. Body mass index in relation to semen quality and reproductive hormones among 1,558 Danish men. Fertil Steril. 2004;82: 863870.
  • Jockenhovel F.. Testosterone therapy—what, when and to whom? Aging Male. 2004;7: 319324.
  • Jorgensen N., Andersen AG, Eustache F., Irvine DS, Suominen J., Petersen JH, Andersen AN, Auger J., Cawood EH, Horte A., Jensen TK, Jouannet P., Keiding N., Vierula M., Toppari J., Skakkebaek NE. Regional differences in semen quality in Europe. Hum Reprod. 2001;16: 10121019.
  • Jorgensen N., Carlsen E., Nermoen I., Punab M., Suominen J., Andersen AG, Andersson AM, Haugen TB, Horte A., Jensen TK, Magnus O., Petersen JH, Vierula M., Toppari J., Skakkebaek NE. East-West gradient in semen quality in the Nordic-Baltic area: a study of men from the general population in Denmark, Norway, Estonia and Finland. Hum Reprod. 2002;17: 21992208.
  • Kamischke A., Heuermann T., Kruger K., von Eckardstein S., Schellschmidt I., Rubig A., Nieschlag E.. An effective hormonal male contraceptive using testosterone undecanoate with oral or injectable norethisterone preparations. J Clin Endocrinol Metab. 2002;87: 530539.
  • Kamischke A., Ploger D., Venherm S., von Eckardstein S., von Eckardstein A., Nieschlag E.. Intramuscular testosterone undecanoate with or without oral levonorgestrel: a randomized placebo-controlled feasibility study for male contraception. Clin Endocrinol (Oxf). 2000;53: 4352.
  • Kamischke A., Venherm S., Ploger D., von Eckardstein S., Nieschlag E.. Intramuscular testosterone undecanoate and norethisterone enanthate in a clinical trial for male contraception. J Clin Endocrinol Metab. 2001;86: 303309.
  • Kesseru-Koos E., Larranaga-Legufa A., Hurtado-Koo H., Scharff HJ. Fertility control with norethindrone enanthate, a long-acting parenteral progestogen. Acta Eur Fertil. 1973;4: 203221.
  • Ku JH, Kim ME, Jeon YS, Lee NK, Park YH. Factors influencing testicular volume in young men: results of a community-based survey. BJU Int. 2002;90: 446450.
  • Liu PY, Swerdloff RS, Christenson PD, Handelsman DJ, Wang C.. Rate, extent, and modifiers of spermatogenic recovery after hormonal male contraception: an integrated analysis. Lancet. 2006;367: 14121420.
  • Meriggiola MC, Bremner WJ. Progestin-androgen combination regimens for male contraception. J Androl. 1997;18: 240244.
  • Meriggiola MC, Costantino A., Saad F., D'Emidio L., Labate Morselli AM, Bertaccini A., Bremner WJ, Rudolph I., Ernst M., Kirsch B., Martorana G., Pelusi G.. Norethisterone enanthate plus testosterone undecanoate for male contraception: effects of various injection intervals on spermatogenesis, reproductive hormones, testis, and prostate. J Clin Endocrinol Metab. 2005;90: 20052014.
  • Nieschlag E., Buchter D., von Eckardstein S., Abshagen K., Simoni M., Behre HM. Repeated intramuscular injections of testosterone undecanoate for substitution therapy in hypogonadal men. Clin Endocrinol (Oxf). 1999;51: 757763.
  • Nieschlag E., Zitzmann M., Kamischke A.. Use of progestins in male contraception. Steroids. 2003;68: 965972.
  • Prader A.. Testicular size: Assessment and clinical importance. Triangle. 1966;7: 240253.
  • Qoubaitary A., Swerdloff RS, Wang C.. Advances in male hormone substitution therapy. Expert Opin Pharmacother. 2005;6: 14931506.
  • Sang GW, Fotherby K., Howard G., Elder M., Bye PG. Pharmacokinetics of norethisterone oenanthate in humans. Contraception. 1981;24: 1527.
  • Schubert M., Minnemann T., Hubler D., Rouskova D., Christoph A., Oettel M., Ernst M., Mellinger U., Krone W., Jockenhovel F.. Intramuscular testosterone undecanoate: pharmacokinetic aspects of a novel testosterone formulation during long-term treatment of men with hypogonadism. J Clin Endocrinol Metab. 2004;89: 54295434.
  • Snyder PJ, Lawrence DA. Treatment of male hypogonadism with testosterone enanthate. J Clin Endocrinol Metab. 1980;51: 13351339.
  • Sokol RZ, Palacios A., Campfield LA, Saul C., Swerdloff RS. Comparison of the kinetics of injectable testosterone in eugonadal and hypogonadal men. Fertil Steril. 1982;37: 425430.
  • Swan SH, Brazil C., Drobnis EZ, Liu F., Kruse RL, Hatch M., Redmon JB, Wang C., Overstreet JW. Geographic differences in semen quality of fertile U.S. males. Environ Health Perspect. 2003;111: 414420.
  • Swerdloff RS, Wang C., Cunningham G., Dobs A., Iranmanesh A., Matsumoto AM, Snyder PJ, Weber T., Longstreth J., Berman N.. Long-term pharmacokinetics of transdermal testosterone gel in hypogonadal men. J Clin Endocrinol Metab. 2000;85: 45004510.
  • Vermeulen A., Kaufman JM, Giagulli VA. Influence of some biological indexes on sex hormone-binding globulin and androgen levels in aging or obese males. J Clin Endocrinol Metab. 1996;81: 18211826.
  • Von Eckardstein S., Nieschlag E.. Treatment of male hypogonadism with testosterone undecanoate injected at extended intervals of 12 weeks: a phase II study. J Androl. 2002;23: 419425.
  • Wang C., Cunningham G., Dobs A., Iranmanesh A., Matsumoto AM, Snyder PJ, Weber T., Berman N., Hull L., Swerdloff RS. Long-term testosterone gel (AndroGel) treatment maintains beneficial effects on sexual function and mood, lean and fat mass, and bone mineral density in hypogonadal men. J Clin Endocrinol Metab. 2004;89: 20852098.
  • Wang C., Swerdloff RS. Male hormonal contraception. Am J Obstet Gynecol. 2004;190: S60S68.
  • Wang C., Wang XH, Nelson AL, Lee KK, Cui YG, Tong JS, Berman N., Lumbreras L., Leung A., Hull L., Desai S., Swerdloff RS. Levonorgestrel implants enhanced the suppression of spermatogenesis by testosterone implants: comparison between Chinese and non-Chinese men. J Clin Endocrinol Metab. 2006;91: 460470.
  • World Health Organization, Laboratory Manual for the Examination of Human Semen and Sperm-Cervical Mucus Interaction. 4th ed. Cambridge, United Kingdom: Cambridge University Press; 1999.
  • World Health Organization Task Force on Methods for the Regulation of Male Fertility. Contraceptive efficacy of testosterone-induced azoospermia and oligozoospermia in normal men. Fertil Steril. 1996;65: 821829.
  • World Health Organization Task Force on Methods for the Regulation of Male Fertility. Contraceptive efficacy of testosterone-induced azoospermia in normal men. Lancet. 1990;336: 955959.
  • Wu FC, Balasubramanian R., Mulders TM, Coelingh-Bennink HJ. Oral progestogen combined with testosterone as a potential male contraceptive: additive effects between desogestrel and testosterone enanthate in suppression of spermatogenesis, pituitary-testicular axis, and lipid metabolism. J Clin Endocrinol Metab. 1999;84: 112122.
  • Zhang GY, Gu YQ, Wang XH, Cui YG, Bremner WJ. A clinical trial of injectable testosterone undecanoate as a potential male contraceptive in normal Chinese men. J Clin Endocrinol Metab. 1999;84: 36423647.
  • Zhang GY, Gu YQ, Wang XH, Cui YG, Bremner WJ. A pharmacokinetic study of injectable testosterone undecanoate in hypogonadal men. J Androl. 1998;19: 761768.